Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 99.12M | 81.10M | 70.78M | 58.71M | 49.90M |
Gross Profit | 81.75M | 65.79M | 59.38M | 39.94M | 31.71M |
EBITDA | 23.62M | 14.52M | 15.22M | 16.32M | 13.55M |
Net Income | 11.53M | 6.58M | 9.51M | 11.12M | 9.46M |
Balance Sheet | |||||
Total Assets | 51.23M | 47.30M | 41.94M | 39.47M | 33.82M |
Cash, Cash Equivalents and Short-Term Investments | 36.39M | 32.73M | 27.39M | 27.81M | 21.43M |
Total Debt | 2.77M | 2.20M | 834.00K | 1.57M | 1.64M |
Total Liabilities | 21.09M | 20.55M | 17.27M | 15.29M | 13.00M |
Stockholders Equity | 30.14M | 26.75M | 24.66M | 24.18M | 20.82M |
Cash Flow | |||||
Free Cash Flow | 21.27M | 16.00M | 15.40M | 15.41M | 8.09M |
Operating Cash Flow | 22.29M | 16.20M | 16.16M | 15.50M | 8.85M |
Investing Cash Flow | -11.17M | -4.07M | -4.12M | -120.00K | 613.00K |
Financing Cash Flow | -11.86M | -6.79M | -12.46M | -9.00M | -6.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | AU$901.39M | 11.76 | 9.29% | 6.77% | 142.41% | 13664.71% | |
76 Outperform | AU$368.71M | 21.84 | 30.97% | 3.99% | 12.05% | 23.63% | |
69 Neutral | AU$878.82M | 50.08 | 4.53% | 3.33% | 9.40% | -27.34% | |
68 Neutral | $17.10B | 11.44 | 9.70% | 3.58% | 11.11% | -4.78% | |
65 Neutral | €874.47M | 57.64 | 47.73% | 1.43% | 19.11% | 24.72% | |
― | €202.88M | 12.51 | 9.63% | 52.40% | ― | ― | |
50 Neutral | AU$1.37B | 30.67 | 10.26% | 2.55% | 31.89% | 45.79% |
Australian Ethical Investment Ltd has announced a change in its substantial holding in Kinatico Limited, with its voting power decreasing from 7.75% to 6.29%. This change reflects a reduction in the number of ordinary shares held, which may impact the company’s influence in Kinatico Limited’s decision-making processes.
Australian Ethical Investment Ltd has announced that it has ceased to be a substantial holder in IPH Limited as of July 17, 2025. This change reflects a shift in the company’s investment portfolio, which may impact its market positioning and influence its stakeholders’ perception regarding its investment strategies.
Australian Ethical Investment Ltd has reported a 34% growth in funds under management (FUM) for the financial year ending June 30, 2025, reaching a record high of $13.94 billion. This growth is attributed to strong quarterly net flows, investment performance, and strategic acquisitions, such as Altius Asset Management. The company has seen increased demand for its ethical investment approach, with significant contributions from superannuation and institutional channels. The integration of Altius has enhanced their fixed income capabilities, contributing to positive institutional net flows. The company’s disciplined investment strategy, limited exposure to fossil fuels, and focus on high-quality opportunities have driven strong investment performance, further solidifying its position in the ethical investment industry.
Australian Ethical Investment Ltd has increased its stake in Oncosil Medical Limited, with its voting power rising from 5.15% to 6.93%. This change in substantial holding reflects the company’s strategic move to enhance its influence in Oncosil Medical, potentially impacting its market positioning and stakeholder interests.
Australian Ethical Investment Ltd has announced a change in the interests of a substantial shareholder in Austco Healthcare Limited. The company’s voting power in Austco Healthcare has decreased from 15.59% to 14.06%, indicating a reduction in their stake. This change in shareholding could impact Australian Ethical’s influence in Austco Healthcare, potentially affecting their strategic decisions and stakeholder relationships.
Australian Ethical Investment Ltd has announced that it has ceased to be a substantial holder in PEXA Group Limited as of June 24, 2025. This change in holding may impact Australian Ethical’s investment strategy and its influence within the PEXA Group, potentially affecting stakeholders’ perceptions of both companies.
Australian Ethical Investment Ltd has become a substantial holder in Oncosil Medical Limited, acquiring a 5.15% voting power through 732,568 ordinary shares. This move signifies Australian Ethical’s strategic interest in the medical sector, potentially enhancing its influence and decision-making capacity within Oncosil Medical, which could impact stakeholders and the company’s market positioning.
Australian Ethical Investment Ltd has increased its stake in Nuix Limited, raising its voting power from 6.10% to 7.15%. This change in substantial holding reflects the company’s strategic decision to enhance its influence in Nuix Limited, potentially impacting its operations and market positioning.
Australian Ethical Investment Ltd has announced its initial substantial holding in IPH Limited, with a voting power of 5.06% through 13,187,892 ordinary shares. This move signifies Australian Ethical’s strategic interest in IPH Limited, potentially impacting its market positioning and offering new opportunities for stakeholders in the ethical investment sector.
Australian Ethical Investment Ltd has announced a change in its substantial holding in Urbanise.com Limited, with its voting power decreasing from 9.11% to 7.44%. This adjustment in shareholding reflects a strategic decision that may influence the company’s influence and decision-making power within Urbanise.com Limited.
Australian Ethical Investment Ltd has increased its stake in Siteminder Limited, as indicated by a recent change in the interests of a substantial shareholder. The company’s voting power in Siteminder has risen from 5.04% to 6.31%, reflecting a strategic move that may enhance its influence and decision-making capacity within the company, potentially impacting Siteminder’s future direction and operations.
Australian Ethical Investment Ltd has increased its stake in Nuix Limited, as indicated by a change in the interests of a substantial shareholder. The company’s voting power in Nuix Limited has risen from 5.10% to 6.10%, reflecting a strategic move to strengthen its influence and investment in the company. This change could potentially impact Nuix’s shareholder dynamics and Australian Ethical’s positioning within the market.